Introduction {#s1}
============

Mechanotransduction, the conversion of physical forces into biochemical signals, is a critical component of cell signaling [@pgen.1003510-Orr1], [@pgen.1003510-Jaalouk1]. Force sensation is essential during organism development and guides cell migration, differentiation, and morphogenesis [@pgen.1003510-Gehler1], [@pgen.1003510-Zhang1]. Mechanotransduction is essential for normal physiological functioning of the cardiovascular, musculoskeletal, and digestive systems; for example, blood vessel diameter decreases in response to pressure increases to maintain consistent blood volume flow [@pgen.1003510-Yin1], [@pgen.1003510-SharifNaeini1]. Cytoskeletal proteins are interconnected in a dynamic, cell-wide structure, and are optimally positioned to sense and transduce changing mechanical parameters [@pgen.1003510-DuFort1]. In addition to acting as primary mechanosensors, cytoskeletal proteins are required to anchor and organize stretch-activated membrane ion channels [@pgen.1003510-Orr1].

Filamins are large cytoskeletal scaffolding proteins that consist of an N-terminal actin-binding domain (ABD), followed by a species- and isoform-dependent number of immunoglobulin-like repeats (IgFLN) [@pgen.1003510-Stossel1], [@pgen.1003510-Nakamura1]. Human filamins contain 24 IgFLN domains, and mutations are associated with a broad spectrum of human diseases, including periventricular heterotopia (FLNA), boomerang dysplasia (FLNB), and various myopathies (FLNC) [@pgen.1003510-Fox1]--[@pgen.1003510-Vattemi1]. Filamin knockout mice show a similar spectrum of phenotypes [@pgen.1003510-Zhou1]--[@pgen.1003510-Dalkilic1]. The Drosophila filamin cheerio is composed of 20 IgFLN domains and is important for formation and function of ring canals and follicle cell motility during oogenesis [@pgen.1003510-Sokol1]--[@pgen.1003510-Sokol2].

Filamins organize the actin cytoskeleton into an elastic three-dimensional network that is responsible for maintaining cell structure and resisting mechanical forces [@pgen.1003510-Schmoller1], [@pgen.1003510-Nakamura2]. Experimental evidence suggests that filamin may act as a force-sensitive molecular scaffold [@pgen.1003510-Stossel1], [@pgen.1003510-Nakamura1], [@pgen.1003510-Ehrlicher1]. Filamin contains cryptic binding sites that are obscured by adjacent domains [@pgen.1003510-Lad1], [@pgen.1003510-Ithychanda1]. Atomic force microscopy data reveal that filamin molecules unfold when stretched and refold when tension is relieved [@pgen.1003510-Furuike1]. Stretching of the filamin rod domain exposes binding sites for integrins and other proteins and leads to strengthening of focal adhesions [@pgen.1003510-Lad1], [@pgen.1003510-Pentikinen1], and a force-dependent filamin-integrin interaction has been observed in cell culture [@pgen.1003510-Gehler1]. In addition to acting as a direct mechanosensor, filamin also acts to connect stretch-activated ion channels, such as polycystins, with the cytoskeleton [@pgen.1003510-SharifNaeini1].

Our previous work focused on the initial characterization of a well-conserved *C. elegans* filamin ortholog FLN-1 [@pgen.1003510-Kovacevic1], [@pgen.1003510-DeMaso1]. FLN-1 consists of an N-terminal ABD followed by 20 IgFLN domains, and is expressed in the spermatheca and uterus, where it colocalizes with F-actin [@pgen.1003510-Kovacevic1], [@pgen.1003510-DeMaso1]. The allele *fln-1(tm545)* deletes a portion of the ABD, and a frameshift disrupts translation of all 20 of the IgFLN domains. Therefore, *tm545* is a likely strong hypomorph or a null allele [@pgen.1003510-Kovacevic1]. The most striking phenotype of the *fln-1(tm545)* animals is the failure of fertilized embryos to exit from the spermatheca [@pgen.1003510-Kovacevic1]. The spermatheca, as part of the *C. elegans* gonad, serves as the site of sperm storage and fertilization [@pgen.1003510-McCarter1]. It consists of three distinct regions: the distal constriction, a central accordion-like bag, and the spermatheca-uterine (sp-ut) valve [@pgen.1003510-Lints1]--[@pgen.1003510-Strome1]. The spermatheca, along with a large portion of the oviduct, is enveloped by a single layer of myoepithelial cells [@pgen.1003510-Strome1]. As oocytes are ovulated over the lifetime of the animal, the spermatheca undergoes numerous cycles of stretching, constriction, and relaxation, making it an ideal system to study the role of FLN-1 in cell response to stretch and coordination of cell signaling in an intact tissue.

During each ovulatory cycle, the most proximal oocyte is ovulated into the spermatheca, fertilized, and then released into the uterus [@pgen.1003510-McCarter1]. Oocyte entry depends on complex signaling between the oocytes, the sperm, and the sheath cells. LIN-3/EGF is secreted by the proximal oocyte and acts on the proximal sheath cells [@pgen.1003510-Clandinin1]. In the sheath, LET-23/EGF receptor is predicted to activate PLC-3/phospholipase C-γ, which generates inositol 1,4,5-triphosphate (IP~3~) and diacylglycerol (DAG) [@pgen.1003510-Clandinin1], [@pgen.1003510-Yin2]. The IP~3~ signal is negatively regulated by IPP-5/inositol 5′-phosphatase and LFE-2/IP~3~ 3′-kinase [@pgen.1003510-Clandinin1], [@pgen.1003510-KimBui1]. ITR-1/IP~3~ receptor releases calcium from the endoplasmic reticulum when stimulated by IP~3~ [@pgen.1003510-Clandinin1]. Calcium likely controls the sheath cell myosin contraction by regulating troponin and tropomyosin [@pgen.1003510-Ono1]. The contraction of the proximal sheath cells propels the oocyte into the spermatheca, where fertilization immediately occurs [@pgen.1003510-McCarter1].

After fertilization, directional constriction of the spermatheca propels the embryo into the uterus [@pgen.1003510-McCarter1]. The molecular mechanism responsible for initiating and regulating spermathecal constriction is poorly understood, but PLC-1/phospholipase C-ε [@pgen.1003510-Kariya1] is required for this process. Loss of PLC-1 results in trapping of embryos in the spermatheca [@pgen.1003510-Kariya1]. PLC-1, like PLC-3, generates IP~3~ and DAG from PIP~2~; however, PLC-ε enzymes are regulated by small GTPases, while PLC-γ enzymes are regulated by receptor tyrosine kinases [@pgen.1003510-Shibatohge1]--[@pgen.1003510-Rhee1]. The specific usage of PLC-3 and PLC-1 in the sheath and the spermatheca suggests that the pathways may be differentially regulated. An increase in cytosolic IP~3~ likely activates ITR-1/IP~3~ receptor (IP~3~R), a tetrameric complex in the endoplasmic reticulum membrane [@pgen.1003510-Clandinin1], [@pgen.1003510-Taylor1]. IP~3~ binding to IP~3~R is insufficient for full activation, which requires concomitant calcium binding [@pgen.1003510-Taylor1], [@pgen.1003510-Foskett1]. Activation of one IP~3~R in turn activates neighboring IP~3~Rs by elevating the local calcium concentration [@pgen.1003510-Taylor1]. Although intermediate calcium concentration stimulates IP~3~R, high calcium concentration has an inhibitory effect [@pgen.1003510-Taylor1]. This biphasic response of IP~3~R to calcium can create regenerating calcium waves in the presence of constant IP~3~ levels [@pgen.1003510-Taylor1].

We propose that the release of calcium by the IP~3~R in the spermathecal cells induces constriction of the spermatheca by activating myosin contraction. In contrast to the sheath cells, the spermatheca does not appear to express a muscle myosin [@pgen.1003510-Ono1]. Smooth muscle regulatory components LET-502/Rho-activated kinase(ROCK) and MEL-11/myosin light chain phosphatase subunit are required for spermathecal function [@pgen.1003510-Wissmann1], suggesting that the spermathecal myosin belongs to the non-muscle myosin class [@pgen.1003510-Piekny1], [@pgen.1003510-HuntNewbury1]. NMY-1/non-muscle myosin II is expressed in the spermatheca [@pgen.1003510-Shibatohge1], and here we show NMY-1 is required for spermathecal constriction.

In this study we use GCaMP, a genetically-encoded calcium indicator, to show that oocyte entry stretches the spermathecal cells and triggers coordinated pulses of calcium transients. The calcium transients originate in the distal constriction and appear to propagate proximally across the spermathecal bag. FLN-1 and PLC-1 are required to trigger calcium signaling, and ITR-1 is required downstream of PLC-1 to produce the calcium oscillations. The signal is coordinated across the tissue via gap junctions to produce a directional wave. The directional wave of calcium results in contraction of the actomyosin network and expulsion of the embryo into the uterus. Given the modular protein structure, sub-cellular localization, genetic interaction data, and known mechanosensory functions of filamin, we postulate that FLN-1 is required to convert physical information about the presence of the oocyte into a calcium signal that controls the directional constriction of the spermatheca.

Results {#s2}
=======

*fln-1* interacts genetically with regulators of calcium signaling in the spermatheca {#s2a}
-------------------------------------------------------------------------------------

Previous studies have revealed an important role for phosphatidylinositol signaling during ovulation and spermathecal transit in *C. elegans*, and demonstrated that PLC-1/phospholipase C-ε is required for spermathecal transit [@pgen.1003510-Clandinin1], [@pgen.1003510-Yin2], [@pgen.1003510-Kariya1]. PLC-1 generates IP~3~, which is thought to trigger calcium release from the endoplasmic reticulum via the IP~3~ receptor ITR-1 [@pgen.1003510-Clandinin1], [@pgen.1003510-Kariya1]. We have shown previously that *fln-1(tm545)* and *plc-1(rx1)* single and double mutants show a very similar phenotype, in which embryos are retained in the spermatheca [@pgen.1003510-Kovacevic1]. Because PLC-1 and FLN-1 are both required in the spermatheca for transit of fertilized oocytes, we explored the possibility that FLN-1 functions in the IP~3~ signaling pathway to regulate spermathecal function.

Strong *itr-1* loss-of-function alleles result in ovulation entry defects, complicating observation of spermathecal transit. To circumvent this problem, we used *itr-1* gain-of-function alleles [@pgen.1003510-Clandinin1], [@pgen.1003510-Yin2]. The *itr-1* gain-of-function alleles are located in or near the IP~3~-binding domain of ITR-1 and are thought to increase the affinity of ITR-1 for IP~3~ [@pgen.1003510-Clandinin1], [@pgen.1003510-Baylis1], [@pgen.1003510-Walker1]. Using brood size assays, we tested five putative *itr-1* gain-of-function alleles for suppression of the *fln-1(tm545)* brood size defect [@pgen.1003510-Kovacevic1]. *itr-1* alleles *sy327gf*, *sy328gf*, and *sy290gf* suppressed the brood size defect ([Figure 1](#pgen-1003510-g001){ref-type="fig"}), while *sy291gf* and *sy331gf* did not (unpublished data).

![*fln-1(tm545)* brood size defect is suppressed by increased IP~3~ signaling.\
Brood sizes of *fln-1(tm545)* animals carrying *itr-1(gf)* and *lfe-2(lf)* mutations. The genotypes are indicated along the y-axis. Points represent individual animals, the bar indicates the mean, and the error bar is the standard deviation. Student\'s t-test was used to compare the genotypes, and p values are indicated with \*\*\* for p = 0.0001.](pgen.1003510.g001){#pgen-1003510-g001}

We chose to focus on the *itr-1(sy290gf)* allele for subsequent experiments because it affects a well-characterized residue critical for IP~3~ binding [@pgen.1003510-Yoshikawa1]. Biochemical characterization suggests that the *sy290* recombinant protein has a two-fold increase in IP~3~ binding affinity [@pgen.1003510-Walker1]. The *itr-1(sy290gf)* animals do not exhibit overt ovulation or spermathecal transit defects; however, the sheath cell contractions are more frequent in these animals and they show a reduced brood size (173±17 SD, n = 6) compared to wildtype animals (301±26 SD, n = 14) [@pgen.1003510-Yin2]. To control for possible effects of the marker phenotypes we used *itr-1(sy290gf)* strains marked with *dpy-20(e1282)* (dumpy) or *unc-24(e138)* (kinker). No brood size differences were observed between the differentially marked strains. Similarly, the brood size of *fln-1(tm545) unc-24(e138)* (20±4 SD, n = 12) animals is not significantly (p = 0.08, Student\'s t-test) different from *fln-1(tm545)* animals. *fln-1(tm545) itr-1(sy290) unc-24(e138)* and *fln-1(tm545) itr-1(sy290) dpy-20(e1282)* animals have a significantly (p\<0.0001, Student\'s t-test) higher average brood size (46±22 SD, n = 18, and 46±12 SD, n = 15, respectively) than *fln-1(tm545)* animals ([Figure 1](#pgen-1003510-g001){ref-type="fig"}).

LFE-2 negatively regulates IP~3~ signaling by phosphorylating IP~3~ into inositol 1,3,4,5-tetrakisphosphate (IP~4~) [@pgen.1003510-Clandinin1]. Therefore, *lfe-2(sy326)*, a loss-of-function allele, is predicted to have longer duration or intensity of IP~3~ signals [@pgen.1003510-Clandinin1]. Like *itr-1(sy290gf)*, *lfe-2(sy326)* does not result in obvious ovulation or spermathecal transit defects, but does exhibit a reduced brood size (174±90 SD, n = 6) compared to wildtype animals (301±26 SD, n = 14). We speculated that increased IP~3~ levels in the *lfe-2(sy326)* background would also suppress the *fln-1(tm545)* spermathecal transit defect. We found that, indeed, *fln-1(tm545)*; *lfe-2(sy326lf)* animals have a significantly (p\<0.0001, Student\'s t-test) increased average brood size (43±27, n = 32) compared to *fln-1(tm545)* animals ([Figure 1](#pgen-1003510-g001){ref-type="fig"}).

Characteristic calcium oscillations control spermathecal transit {#s2b}
----------------------------------------------------------------

Because we observed a genetic interaction between *fln-1* and components of the phosphatidylinositol signaling pathway, we next examined whether calcium signaling plays a role during spermathecal transit. It has been hypothesized that IP~3~R-regulated calcium release results in sheath cell contractions, however, IP~3~R-regulated calcium release has not been observed directly in the sheath or the spermatheca. To monitor calcium levels during spermathecal transit we used GCaMPv3 (GFP-Calmodulin-M13 Peptide, version 3), a genetically-encoded calcium indicator [@pgen.1003510-Tian1]. GCaMP has been previously used in *C. elegans* neurons and hypodermal cells to image calcium transients [@pgen.1003510-Tian1], [@pgen.1003510-Xu1].

We created transgenic nematodes expressing GCaMP under the control of the *fln-1* promoter (*xbIs1101\[fln-1p::GCaMP\]*), imaged immobilized animals using wide-field epifluorescence with standardized acquisition parameters, and quantified the GCaMP signal by calculating mean pixel intensity (pixel intensity/area) and normalizing to the initial fluorescence ([Figure 2A](#pgen-1003510-g002){ref-type="fig"}). Importantly, animals expressing GCaMP exhibit wildtype oocyte entry, ovulation transit times, and normal brood sizes (282±51 SD, n = 6; compare Video S1 and Video S2). Animals expressing regular calcium-insensitive *fln-1p::GFP* were used as controls to determine whether spermathecal shape changes or photobleaching would affect the GCaMP signal ([Figure 2C](#pgen-1003510-g002){ref-type="fig"}, Video S2). No alteration in GFP fluorescence signal due to spermathecal shape changes was observed, and photobleaching was not detected over many hours of imaging (n = 6) ([Figure 2C](#pgen-1003510-g002){ref-type="fig"}, Video S2). As an additional control for possible effects of changing cell shapes on measured intensities, we expressed tdTomato and GCaMP in the spermatheca and performed ratiometric imaging. Because the tdTomato signal remained constant throughout the duration of imaging, normalization of GCaMP to tdTomato signal did not result in any significant differences in signal compared to non-ratiometric imaging (n = 3) ([Figure S1](#pgen.1003510.s001){ref-type="supplementary-material"}).

![Oocyte entry into the spermatheca triggers calcium oscillations.\
(A--B′) A representative first ovulation in *xbIs1101\[fln-1p::GCaMP\]* (n = 26) transgenic animals. (A) A plot of GCaMP mean pixel intensity normalized to the pre-ovulation mean pixel intensity is shown, along with a (A′) corresponding kymogram at the same time scale. The top and bottom of the kymogram represent the distal and proximal spermatheca, respectively. Darker regions indicate higher calcium levels. Oocyte entry begins at 30 seconds and is complete by 60 seconds, and the zygote exit is marked by a magenta arrowhead in (A) and is visible in (A′) as a reduction in the size of the spermatheca. (A′) The leftward tilt of dark stripes is indicative of calcium transient propagation from the distal spermatheca. (B--B′) A detailed view of several calcium transients is shown as a (B) trace and (B′) kymogram from the region indicated by the blue line in (A). (B) GCaMP fluorescence intensity was quantified in 1 µm strips (distal is black, and proximal is gray), 50 µm apart as indicated in (B′). The mean peak-to-peak transit time across the spermatheca is 8±1 seconds and is indicated on the trace in (B). (C) A representative first ovulation in *xbEx0811\[fln-1p::GFP\]* (n = 6) transgenic animals. The *fln-1p::GFP* signal does not change during oocyte entry or spermathecal transit. (C′) A corresponding kymogram of *fln-1p::GFP* spermathecal transit with oocyte entry and sp-ut valve dilation visible as dark horizontal stripes.](pgen.1003510.g002){#pgen-1003510-g002}

Time-lapse imaging of GCaMP reveals that oocyte entry into the spermatheca initiates a characteristic and reproducible sequence of calcium oscillations (n = 26) ([Figure 2](#pgen-1003510-g002){ref-type="fig"}, Video S1). Out of necessity we focused our analysis of calcium signaling on the first ovulation; however, in wild type animals, generally similar calcium transients are observed in subsequent ovulations ([Figure S2](#pgen.1003510.s002){ref-type="supplementary-material"}). Oocyte entry into the spermatheca consistently triggers a single pulse of calcium in the sp-ut valve ([Figure 2A′](#pgen-1003510-g002){ref-type="fig"}, Video S1). The single pulse of calcium in the sp-ut valve may serve to constrict the valve to prevent premature exit of the oocyte. Neither fertilization nor egg shell formation are required to initiate spermathecal calcium signaling ([Figure S3](#pgen.1003510.s003){ref-type="supplementary-material"}). Following complete entry of the oocyte into the spermatheca, the calcium transients increase in intensity as the oocyte progresses through the spermatheca ([Figure 2A and B](#pgen-1003510-g002){ref-type="fig"}, Video S1). Embryo exit is concomitant with the strongest calcium pulses, suggesting that the calcium pulses trigger spermathecal constriction ([Figure 2A](#pgen-1003510-g002){ref-type="fig"}). The final pulse of calcium coincides with constriction of the sp-ut valve following embryo exit ([Figure 2A′](#pgen-1003510-g002){ref-type="fig"}).

Quantitative analysis of the time-lapse image sequences shows that the calcium transients appear to initiate in the distal spermatheca and propagate proximally ([Figure 2A′--2B′](#pgen-1003510-g002){ref-type="fig"}). To determine if the calcium transients are directional we measured the fluorescence intensity in the distal and proximal spermatheca ([Figure 2B](#pgen-1003510-g002){ref-type="fig"}). Calcium pulses are first detected in the distal spermatheca, and then in the proximal spermatheca several seconds later ([Figure 2A′--2B′](#pgen-1003510-g002){ref-type="fig"}). The calcium transients occur in the direction of oocyte movement, suggesting that directional calcium pulses may control spermathecal constriction. The distal spermathecal cells may act as a pacemaker to trigger and synchronize calcium release in other spermathecal cells.

We predicted that the observed distal to proximal spread of the calcium signal would require cell-cell communication and tissue level coordination. To test this idea, we used RNAi to sequentially deplete the 25 gap junction subunits [@pgen.1003510-Altun1], [@pgen.1003510-Starich1], and determined that loss of the innexin INX-12 results in spermathecal transit defects. In *inx-12(RNAi)* animals, oocytes enter the spermatheca normally, but variably change direction several times before returning into the ovary or proceeding into the uterus ([Figure 3](#pgen-1003510-g003){ref-type="fig"}, Video S3). Calcium imaging of the *inx-12(RNAi)* (n = 4) animals revealed that each spermathecal cell is capable of producing calcium pulses, but that the resulting calcium waves are asynchronous and non-directional ([Figure 3A′](#pgen-1003510-g003){ref-type="fig"}, Video S3). The random calcium pulses likely result in the observed uncoordinated spermathecal constriction. These results suggest that a small molecule, such as calcium or IP~3~, propagates through the spermatheca via gap junctions to produce synchronous and directional calcium transients.

![Gap junction subunit INX-12 is required for spermathecal coordination.\
(A) A representative calcium signal trace observed during the first ovulation in *inx-12(RNAi)* (n = 4) animals imaged with *xbIs1101\[fln-1p::GCaMP\]*. The oocyte fails to exit into the uterus and changes direction thrice before returning into the ovary. The arrows indicate direction of movement with blue arrows indicating movement towards the uterus. (A′) Arrowheads in the corresponding kymogram indicate bursts of calcium and correspond to the contractions that stop the oocyte from being refluxed into the ovary. In the kymogram, darker values indicate higher calcium levels. Top is distal, bottom is proximal, and the kymogram is at the same time scale as the calcium trace shown above it.](pgen.1003510.g003){#pgen-1003510-g003}

FLN-1, PLC-1, and ITR-1 are essential for normal calcium signaling in the spermatheca {#s2c}
-------------------------------------------------------------------------------------

To investigate whether FLN-1 is required for normal calcium signaling during spermathecal transit, we introduced the *fln-1p::GCaMP* transgene into *fln-1(tm545)* animals. Although the initial entry pulse of calcium within the sp-ut valve occurs normally ([Figure 4A and 4A′](#pgen-1003510-g004){ref-type="fig"}, Video S4), filamin-deficient animals fail to initiate calcium transients in the spermatheca itself, with few calcium signals observed during the time normally required for oocyte transit (n = 19) ([Figure 4A](#pgen-1003510-g004){ref-type="fig"}, Video S4). Abnormal and highly variable transients are observed in *fln-1(tm545)* animals approximately 15 minutes after oocyte entry---well after the time a wildtype zygote would have exited ([Figure 4A](#pgen-1003510-g004){ref-type="fig"}). These delayed calcium pulses fail to produce significant constriction of the spermatheca ([Figure 4A′](#pgen-1003510-g004){ref-type="fig"}, Video S4), suggesting that the contractile mechanism may be compromised in filamin-deficient animals. These data suggest that filamin is required for timely initiation of calcium signaling and for the contractile mechanism, but not for the calcium release mechanism per se.

![FLN-1 and PLC-1 are required for different aspects of calcium signaling.\
Representative calcium signal traces observed during the first ovulation in (A) *fln-1(tm545)* (n = 19), (B) *plc-1(rx1)* (n = 5), and (C) *fln-1(tm545); plc-1(rx1)* (n = 3) animals imaged using *xbIs1101\[fln-1p::GCaMP\]*. Corresponding kymograms (A′--C′) are also shown. In the kymograms, darker values indicate higher calcium levels. Top is distal, bottom is proximal, and each kymogram is at the same time scale as the calcium trace shown above it.](pgen.1003510.g004){#pgen-1003510-g004}

Homology and genetic interaction data suggest that hydrolysis of PIP~2~ by PLC-1 generates IP~3~ in the spermatheca, triggering intracellular calcium release via the IP~3~R [@pgen.1003510-Kariya1], [@pgen.1003510-VzquezManrique1]. Consistent with this idea, *plc-1(rx1)* animals fail to produce calcium signals following oocyte entry into the spermatheca (n = 5) ([Figure 4B](#pgen-1003510-g004){ref-type="fig"}, Video S5). *plc-1(rx1)* animals also do not produce the initial entry pulse of calcium in the sp-ut valve. Likewise, a temperature-sensitive reduction-of-function allele of *itr-1(sa73ts)* results in abnormal calcium signaling at the semi-permissive temperature of 20°C [@pgen.1003510-Espelt1]--[@pgen.1003510-Iwasaki1]. Phenotypes observed range from mild perturbations ([Figure 5A](#pgen-1003510-g005){ref-type="fig"}) to grossly abnormal calcium transients (n = 6) ([Figure 5B](#pgen-1003510-g005){ref-type="fig"}). The grossly abnormal calcium signaling is of lower intensity, and results in trapping of embryos within the spermatheca. Additionally, *itr-1(sa73ts)* animals do not produce the initial pulse of calcium in the sp-ut valve during oocyte entry, the timing between pulses is longer, and the calcium release is restricted to the distal spermatheca ([Figure 5](#pgen-1003510-g005){ref-type="fig"}). These results suggest that the observed calcium transients in the spermatheca require IP~3~-regulated release of calcium from internal stores, and are consistent with previous findings in the *C. elegans* intestine [@pgen.1003510-Espelt1], [@pgen.1003510-DalSanto1].

![*itr-1(sa73ts)* disrupts calcium signaling at the semi-permissive temperature.\
Representative calcium signaling traces in *itr-1(sa73ts)* animals at the semi-permissive temperature of 20°C imaged with *xbIs1101\[fln-1p::GCaMP\]*. (A) At the non-permissive temperature, 66% (n = 6) of the *itr-1(sa73ts)* successfully propelled oocytes from the spermatheca into the uterus. (B) The remaining ovulations resulted in embryos trapped within the spermatheca. Corresponding kymograms (A′ and B′) are also shown. In the kymograms, darker values indicate higher calcium levels. Top is distal, bottom is proximal, and each kymogram is at the same time scale as the calcium trace shown above it. In both groups the calcium pulse intensity was markedly reduced compared to wildtype animals. In all cases the *itr-1(sa73ts)* ovulations resulted in a portion of the oocyte being pinched off during ovulation.](pgen.1003510.g005){#pgen-1003510-g005}

Unlike *fln-1(tm545)* single mutant animals, which eventually initiate abnormal calcium pulses, *fln-1(tm545)*; *plc-1(rx1)* double mutant animals behave like *plc-1(rx1)* single mutants and fail to produce any calcium transients (n = 3) ([Figure 4C](#pgen-1003510-g004){ref-type="fig"}, Video S6). This suggests that the delayed calcium pulses seen in *fln-1(tm545)* animals are generated via the canonical phosphatidylinositol signaling pathway. Although FLN-1 is required for timely initiation of calcium pulses upon oocyte entry, it appears that calcium signaling can eventually be activated by a parallel, filamin-independent pathway.

Because gain-of-function mutations that sensitize ITR-1 to IP~3~ suppress the *fln-1(tm545)* brood size defects ([Figure 1](#pgen-1003510-g001){ref-type="fig"}), we next determined the effect of these mutations on calcium signaling in the spermatheca. We speculated that increased sensitivity of ITR-1 to IP~3~ would trigger increased calcium release. *itr-1(sy290gf)* only has a moderate effect on GCaMP intensity in the wildtype background (n = 5) ([Figure S4A](#pgen.1003510.s004){ref-type="supplementary-material"}), which is consistent with the lack of a strong phenotype. We do not detect overt changes in *itr-1(sy290gf)* calcium dynamics, such as increased propagation speed nor increased frequency of calcium release; however, it is possible that there are higher frequency changes not captured by our imaging parameters. Surprisingly, *fln-1(tm545) itr-1(sy290gf)* double mutants have markedly increased calcium signaling immediately following embryo entry (n = 3) ([Figure 6A](#pgen-1003510-g006){ref-type="fig"}, Video S7), and display a novel partial exit phenotype with the embryo held in place by a partially closed sp-ut valve ([Figure 6A′](#pgen-1003510-g006){ref-type="fig"}). Sp-ut valve constriction around the zygote during eggshell formation results in bow tie-shaped embryos (Video S7). *lfe-2(sy326)* animals, like *itr-1(sy290gf)*, have marginally increased intensity of calcium signaling in the wildtype background (n = 4) ([Figure S4B](#pgen.1003510.s004){ref-type="supplementary-material"}). However, the calcium transients in *lfe-2(sy326)* animals are variable from animal to animal, which is consistent with our brood size data ([Figure 1](#pgen-1003510-g001){ref-type="fig"}), and may reflect incomplete penetrance of the *sy326* allele. Similar to the results with *itr-1(sy290gf)*, *fln-1(tm545)*; *lfe-2(sy326)* animals exhibit increased calcium signaling compared to *fln-1(tm545)* alone (n = 3) ([Figure 6B](#pgen-1003510-g006){ref-type="fig"}, Video S8), and partial exit of embryos from the spermatheca ([Figure 6B′](#pgen-1003510-g006){ref-type="fig"}, Video S8). Importantly, these observations indicate that the *fln-1(tm545)* spermatheca and valve may be structurally capable of constriction if sufficient calcium is present.

![Increased IP~3~ signaling suppresses the *fln-1(tm545)* calcium signaling defect.\
Representative calcium signal traces observed during the first ovulation in (A) *fln-1(tm545) itr-1(sy290gf)* (n = 3) and (B) *fln-1(tm545); lfe-2(sy326)* (n = 3) animals imaged with *xbIs1101\[fln-1p::GCaMP\]*. The corresponding kymograms (A′ and B′) are shown below the plots. Arrowheads indicate the beginning of partial exit of the embryo from the spermatheca. In the kymograms, darker values indicate higher calcium levels. Top is distal, bottom is proximal, and each kymogram is at the same time scale as the calcium trace shown above it.](pgen.1003510.g006){#pgen-1003510-g006}

NMY-1/non-muscle myosin functions in the spermatheca {#s2d}
----------------------------------------------------

Cell contractility is generated by the actomyosin cytoskeleton, which consists of myosin, myosin regulatory proteins, and F-actin. Two non-muscle myosin regulatory proteins, Rho-activated kinase LET-502 and a subunit of myosin light chain phosphatase MEL-11, are known to be required for normal spermathecal function [@pgen.1003510-Wissmann1]. The non-muscle myosin NMY-1, redundantly expressed with NMY-2 during embryonic elongation, is strongly expressed in the spermatheca [@pgen.1003510-Piekny1], [@pgen.1003510-HuntNewbury1]. NMY-1, MEL-11, and LET-502 have been extensively studied in the context of embryonic elongation where they are required to fine-tune contractility of the hypodermal cells [@pgen.1003510-Wissmann1], [@pgen.1003510-Piekny1], [@pgen.1003510-Piekny2]--[@pgen.1003510-Diogon1]. We speculated that this contractile module also functions in the spermatheca and is responsible for constriction of the spermatheca.

Similar to the phenotype seen in *fln-1(tm545)* animals, depletion of *nmy-1* by RNAi results in a poorly contractile spermatheca and an sp-ut valve that fails to constrict and completely expel the embryo ([Figure 7](#pgen-1003510-g007){ref-type="fig"}). Embryos are pushed out of *nmy-1(RNAi)* spermathecae through a relaxed sp-ut valve due to back pressure from newly ovulated oocytes. In contrast, in *mel-11(sb56)* animals, oocytes fail to enter into a hyper-constricted spermatheca [@pgen.1003510-Wissmann1]. We speculated that *mel-11(RNAi)* might produce a weaker phenotype than the *sb56* allele. Indeed, *mel-11(RNAi)* animals are able to ovulate, allowing observation of the spermathecal transit process (Video S9). Depletion of *mel-11* in the spermatheca results in hyper-constriction of the spermatheca around the zygote, rupture of the spermatheca, and escape of the zygote into the body cavity ([Figure 8A](#pgen-1003510-g008){ref-type="fig"}, Video S9). The distal constriction and the sp-ut valve also appear to hyper-constrict, forcing the embryo in this unusual direction. The *mel-11* spermathecal rupture phenotype is strongly suppressed in the *fln-1* ([Figure 8B](#pgen-1003510-g008){ref-type="fig"}) and *plc-1* ([Figure 8C](#pgen-1003510-g008){ref-type="fig"}) backgrounds, consistent with the idea that FLN-1 and PLC-1 are required for spermathecal contractility.

![NMY-1 is required for spermathecal contractility.\
The spermatheca appears compact before the first ovulation (A, C, E), however, the sp-ut valve is constricted only in (A′) wildtype animals but not in (C′) *fln-1(tm545)* and (E′) *nmy-1(RNAi)* animals. (B) The wildtype spermatheca and (B′) sp-ut valve fully expel the embryo and re-constrict following every ovulation. In contrast, (D) *fln-1(tm545)* and (F) *nmy-1(RNAi)* spermathecae retain embryos, and the sp-ut valves (D′ and F′, respectively) remain open. The spermatheca is labeled with *ezIs2\[fkh-6p::GFP\]* (images merged with DIC) and the sp-ut valve is labeled with *xbEx1019\[tag-312p::GFP\]*. Arrowheads indicate the sp-ut valve. Vertical lines next to the sp-ut valves indicate the width of the opening. The scale bar indicates 25 µm.](pgen.1003510.g007){#pgen-1003510-g007}

![MEL-11 modulates spermathecal contractility.\
(A) *mel-11(RNAi)* results in hyper-constriction and rupture of the spermatheca. The asterisk indicates an escaped embryo and arrowheads indicate cell fragments in the pseudocoelom. *mel-11(RNAi)* in the (B) *fln-1(tm545)* or (C) *plc-1(rx1)* genetic background does not result in spermathecal rupture. The spermatheca is labeled with *ezIs2\[fkh-6p::GFP\]* and the fluorescent image is merged with DIC. The scale bar indicates 25 µm.](pgen.1003510.g008){#pgen-1003510-g008}

Discussion {#s3}
==========

Our previous work described the *C. elegans* filamin orthologs, and established that FLN-1 is required for function of the spermatheca, a smooth muscle-like tissue in the *C. elegans* gonad [@pgen.1003510-Kovacevic1], [@pgen.1003510-DeMaso1]. Filamin-deficient spermathecae are unable to constrict, and as a result trap fertilized embryos [@pgen.1003510-Kovacevic1]. In this study, we show that oocyte entry into the spermatheca triggers calcium oscillations that are likely instructive for spermathecal constriction. We find that FLN-1, an actin-binding protein and a known mechanosensitive scaffold, is required to trigger timely IP~3~-dependent calcium release in response to oocyte entry. We identify a gap junction subunit, INX-12, required for signal propagation across the spermatheca and the non-muscle myosin, NMY-1, required for spermathecal constriction. Our working hypothesis is that filamin is required in the spermatheca to transduce the physical presence of an oocyte into a biochemical signal, thereby triggering constriction of the spermatheca and expulsion of the embryo ([Figure 9](#pgen-1003510-g009){ref-type="fig"}).

![Proposed genetic control of calcium signaling in the spermatheca.\
The diagram represents a working model of the spermathecal calcium signaling pathway. Green lines indicate interactions that promote cell contraction, and magenta lines indicate those which inhibit contraction. Dashed lines indicate possible regulatory interactions. We propose FLN-1 acts upstream or in parallel to PLC-1 to initiate calcium release via ITR-1. FLN-1 also plays a downstream role in contraction and maintenance of the F-actin cytoskeleton.](pgen.1003510.g009){#pgen-1003510-g009}

Constriction of the spermatheca in response to stretch is reminiscent of myogenic response seen in vascular smooth muscle cells, where increased intraluminal pressure in blood vessels results in vasoconstriction [@pgen.1003510-Orr1], [@pgen.1003510-Voets1]. The myogenic response is triggered via mechanically-sensitive ion channels that stimulate IP~3~-dependent calcium release. Filamin is required for cytoskeletal anchoring of an inhibitory polycystin channel subunit [@pgen.1003510-SharifNaeini1]. Filamin also interacts with other transmembrane channels, such as cystic fibrosis transmembrane regulator (CFTR) [@pgen.1003510-Playford1], Ca(v)1.4 subunit of a voltage-gated L-type channel [@pgen.1003510-Lodha1], pacemaker channel HCN1 [@pgen.1003510-Gravante1], G protein-coupled calcium-sensing receptor [@pgen.1003510-Zhang2], and potassium channels Kir2.1 [@pgen.1003510-Sampson1] and Kv4.2 [@pgen.1003510-Petrecca1]. Filamin therefore appears to be required for normal channel function, and may mechanically couple the channels to the cytoskeleton, as well as controlling their localization [@pgen.1003510-Nakamura1], [@pgen.1003510-vanderFlier1].

Our calcium signaling and genetic interaction data are consistent with the possibility that FLN-1 might act as a top-level component in the spermatheca signal transduction pathway ([Figure 9](#pgen-1003510-g009){ref-type="fig"}). However, the molecular details of how filamin might initiate this cascade are unknown. One possibility is that filamin may be a necessary adaptor between stretch-gated ion channels and the cytoskeleton. Strain on the cytoskeleton would then be communicated to the ion channels, allowing a brief influx of calcium ions which could activate PLC-1 either directly via its EF hand domain [@pgen.1003510-Seifert1] or indirectly through a calcium/calmodulin-activated protein. In addition to connecting the stretch-gated channels to the cytoskeleton, filamin might also scaffold downstream effectors required to sense or amplify ion channel opening.

Another possibility is that filamin is a direct mechanosensor, and that stretch of the spermathecal cells by oocyte entry directly stretches the filamin molecule, thereby revealing cryptic binding sites. Evidence from biophysical experiments with purified components [@pgen.1003510-Ehrlicher1], [@pgen.1003510-Ithychanda1], and study of the mechanosensory role of filamin in the context of focal adhesions in cultured cells support this idea [@pgen.1003510-Nakamura1], [@pgen.1003510-Kainulainen1]--[@pgen.1003510-Shifrin1]. Stretch-activated binding sites could localize a RhoGEF, such as Trio [@pgen.1003510-Bellanger1], to the cortex and increase the level of Rho-GTP, which has been shown to activate PLC-ε [@pgen.1003510-Wing1], [@pgen.1003510-Song1]. Because PLC-ε also contains a GEF domain, activation of PLC-1 may lead to prolonged activation and increased levels of Rho-GTP in addition to IP~3~ and DAG [@pgen.1003510-Seifert2]--[@pgen.1003510-Lopez1]. Activation of ROCK and calcium release would both act to promote contraction. Other downstream pathways could also be activated by DAG and calcium, such as Protein Kinase C (PKC) [@pgen.1003510-Lipp1].

Filamin may perform a partially separable signaling and structural role in the spermatheca. We have shown previously that loss of filamin results in a progressive disorganization of filamentous actin in the spermatheca ([Figure 9](#pgen-1003510-g009){ref-type="fig"}) [@pgen.1003510-Kovacevic1]. F-actin organization is relatively normal initially; however, filamin is required to maintain cytoskeletal structure as the spermatheca is repeatedly stretched by incoming oocytes [@pgen.1003510-Kovacevic1]. Because our calcium measurements are made during the first ovulation, before the actin cytoskeleton becomes grossly abnormal, and because calcium signaling can be strongly disrupted, for example, by loss of PLC-1, in spermathecae with intact actin cytoskeletons, we suspect that the calcium signaling defects in filamin-deficient animals are not simply a consequence of cytoskeletal defects, but we cannot entirely exclude this possibility.

While our results suggest FLN-1 is needed to trigger normal calcium release in the spermatheca, FLN-1 may be acting in parallel with PLC-1 to activate calcium release via ITR-1. We show *itr-1(sy290gf)* and *lfe-2(sy326)* ameliorate the effects of *fln-1(tm545)*, suggesting that they function downstream of *fln-1*. Consistent with this result, over-expression of LFE-2 under a heat-shock promoter results in an exit defect similar to *fln-1(tm545)* [@pgen.1003510-Clandinin1]. The brood size defect of *plc-1(rx1)* animals is not suppressed by *itr-1(sy290gf)* nor *lfe-2(sy326)*, presumably due to complete absence of IP~3~ [@pgen.1003510-Kariya1], [@pgen.1003510-VzquezManrique1]. This suggests that *fln-1(tm545)* animals possess sufficient IP~3~ to activate the sensitized ITR-1 receptor. Therefore a key role of FLN-1 might be to regulate some aspect of ITR-1 response to IP~3~, ultimately resulting in calcium release and spermathecal constriction.

Although IP~3~ appears to be needed to initiate calcium signaling, we do not know whether IP~3~ levels oscillate, or whether IP~3~ simply triggers the first calcium transient. Increased IP~3~ levels due to inactivation of LFE-2, an IP~3~ kinase, or a hypersensitive IP~3~ receptor do not cause abnormal calcium oscillations in the wildtype background, suggesting that precise control of IP~3~ level is not required. Once triggered, IP~3~R may be capable of generating self-sustaining calcium oscillations [@pgen.1003510-Taylor1], [@pgen.1003510-Foskett1], [@pgen.1003510-Watras1], [@pgen.1003510-Jafri1]. IP~3~ binding to IP~3~R stimulates the release of calcium into the cytosol, which initially stimulates IP~3~R, but becomes inhibitory at high concentrations ([Figure 9](#pgen-1003510-g009){ref-type="fig"}) [@pgen.1003510-Taylor1], [@pgen.1003510-Foskett1]. Endoplasmic reticulum Ca^2+^-ATPase pumps then remove calcium from the cytosol, returning calcium levels to the stimulatory range. This repeating cycle results in oscillating calcium levels. Sensitivity of the IP~3~R to IP~3~ and calcium may be modulated by accessory proteins [@pgen.1003510-Foskett1], which may explain the increasing amplitude of calcium release in the spermatheca. With each round of calcium release, ITR-1 may become more activated, leading to larger pulses of calcium. The calcium oscillations may be terminated by an extrinsic signal or a threshold effect of calcium and IP~3~.

Our observations suggest that calcium pulses are initiated in the distal spermatheca and spread proximally. Although loss of the gap junction subunit INX-12 disrupts the synchronous transients, all spermathecal cells appear to be capable of producing stochastic calcium pulses cell-autonomously. Gap junctions generally permit passive diffusion of small solutes, such as calcium and IP~3~. Interestingly, the diffusion of calcium within a cell is limited to small domains by the buffering effects of calcium-binding proteins [@pgen.1003510-Jafri1], [@pgen.1003510-Wagner1], while the diffusion rate of IP~3~ is much greater, allowing it to act as a global messenger [@pgen.1003510-Berridge1]. Given these diffusion rates it seems likely that IP~3~ is primarily responsible for synchronization of calcium signaling in the spermatheca.

We observed that strengthening and synchronization of the calcium signal coincides with a steady, coordinated contraction of the spermathecal tissue and expulsion of the fertilized embryo. Spermathecal contraction requires the non-muscle myosin NMY-1. Smooth muscle cell contraction is regulated by phosphorylation of the regulatory myosin light chain (rMLC) by MLC kinase (MLCK) [@pgen.1003510-Somlyo1]. The *C. elegans* genome lacks an obvious MLCK homolog, suggesting that rMLC phosphorylation is regulated by other kinases, such as ROCK ([Figure 9](#pgen-1003510-g009){ref-type="fig"}) [@pgen.1003510-Batchelder1]. In *C. elegans* loss of LET-502/ROCK leads to loss of contractility of the spermatheca [@pgen.1003510-Wissmann1], [@pgen.1003510-Piekny2], [@pgen.1003510-Wissmann2]. Contractility is negatively regulated by dephosphorylation of the rMLC by MLCP, and in *C. elegans* loss of MEL-11, an MLCP subunit, leads to hyper-constriction of the spermatheca. Understanding how this contractile module is regulated by calcium signals is an exciting future area of study.

In summary, in this study we demonstrate that oocyte entry leads to dynamic calcium signaling and coordinated contraction of the tissue, ultimately leading to expulsion of the fertilized embryo. We further demonstrate that FLN-1, PLC-1, ITR-1 and the gap junction component INX-12 are required for normal calcium signaling in the spermatheca. These results establish filamin as a regulator of calcium signaling, and suggest disruption of filamin may result in defective cell response to stretch. This is important because human filamin mutations result in severe myopathies, cardiovascular, and neurological conditions, but it is unclear how loss of filamin results in these diverse pathologies. Our study shows that filamin, in addition to being a cytoskeletal protein, may modulate calcium signaling pathways in spermathecal and other mechanically-sensitive cells. In addition to providing mechanistic insight into how the spermatheca functions, this study helps to establish the spermatheca as an *in vivo* model system for the study of how cells coordinate tissue-level responses to mechanical input.

Materials and Methods {#s4}
=====================

*C. elegans* strains and culture {#s4a}
--------------------------------

*C. elegans* strains were cultured on NGM agar plates with OP50 *Escherichia coli* at 20°C. Nematode observations and manipulations were performed at 20°C unless otherwise noted. For a complete list of strains used in this study please see [Table S1](#pgen.1003510.s005){ref-type="supplementary-material"}. Standard genetic techniques were used to manipulate *C. elegans* genotypes. Point mutations were tracked with marker alleles. *unc-24(e138)*, a weak kinker allele, was used to follow the *itr-1* gain-of-function alleles. *dpy-20(e1282)*, a dumpy allele, was also used to follow *itr-1(sy290gf)* to control for any marker phenotypes. *unc-57(ad592)*, another weak kinker allele was used to follow *lfe-2(sy326)*. Deletion and insertion alleles were genotyped using polymerase chain reaction (PCR).

RNA interference {#s4b}
----------------

RNA interference was performed by feeding animals dsRNA-expressing HT115 DE3 *E. coli* as described [@pgen.1003510-Kovacevic1], [@pgen.1003510-Cram1]. The RNAi bacteria were seeded onto NGM plates supplemented with carbenicillin and isopropyl β-D-1-thiogalactopyranoside (IPTG). Eggs were obtained from gravid hermaphrodites using alkaline hypochlorite solution and placed on the RNAi plates. RNAi targeting constructs for *fln-1* [@pgen.1003510-Kovacevic1], *nmy-1*, and *plc-1* were constructed by PCR amplification of wildtype cDNA using engineered restriction sites, and subsequently cloned into pPD129.36 (Fire Vector Kit). Primer sequences used for plasmid construction are shown in [Table S2](#pgen.1003510.s006){ref-type="supplementary-material"}. *mel-11* RNAi targeting construct was isolated from an open reading frame RNAi library (Open Biosystems; Huntsville, AL, USA). Empty pPD129.36 vector was used as a negative control in RNAi experiments.

Gap junction subunit RNAi screen {#s4c}
--------------------------------

We used RNA interference to individually deplete the 25 predicted gap junction genes [@pgen.1003510-Altun1], [@pgen.1003510-Starich1] in *xbIs1101\[fln-1p::GCaMP\]* animals. RNAi experiments were performed as described above. RNAi targeting constructs were obtained from an open reading frame RNAi library (Open Biosystems; Huntsville, AL, USA) or constructed by PCR amplification of wildtype cDNA and subsequent cloning into pPD129.36 (Fire Vector Kit). Primer sequences are provided in [Table S2](#pgen.1003510.s006){ref-type="supplementary-material"}. We used a low-magnification screen to identify animals with distended spermathecae or embryos present in the ovary as indicators of abnormal spermathecal function. We excluded genes that grossly affected animal development or gonad morphology. Primary screen hits were selected for detailed calcium imaging as described below.

Brood size assays {#s4d}
-----------------

We define brood size as the number of hatched progeny. The total number of hatchlings was determined by segregating L4 animals to individual, freshly seeded plates. Progeny were counted and aspirated beginning two days after the initial transfer, and continuing for two days after end of egg laying. Brood sizes are reported as the mean ± standard deviation. Two-tailed, unpaired t-tests were used to test for statistical significance between relevant genotypes. Statistical analyses were performed using GraphPad Prism 5.

Construction of *fln-1p::GCaMP* transgenic animals {#s4e}
--------------------------------------------------

GCaMP3 was obtained from Addgene plasmid 22692 [@pgen.1003510-Tian1]. PCR was used to amplify GCaMP with primers IK189 and IK190 ([Table S2](#pgen.1003510.s006){ref-type="supplementary-material"}) containing engineered restriction endonuclease sites XbaI and XmaI. The XbaI-XmaI fragment was cloned downstream of the *fln-1* promoter in pUN85 [@pgen.1003510-Kovacevic1] to generate pUN107. pUN107 contains the *fln-1* promoter, GCaMP, and the *fln-1* 3′ UTR. Transgenic animals were created by microinjecting a DNA solution containing 40 ng/µL of pUN107 and 100 ng/µL of pRF4 (*rol-6* marker). Progeny displaying the roller phenotype and green fluorescence in the spermatheca were segregated to establish transgenic lines. A strain (UN1037) with low levels of GCaMP expression and moderate transmission frequency was integrated using UV irradiation to generate strain UN1101 *xbIs1101\[fln-1p::GCaMP\] II*. UN1101 was outcrossed ten times to create strain UN1108. Standard genetic crosses were used to introduce *xbIs1101* into various genetic backgrounds.

Time-lapse microscopy {#s4f}
---------------------

### Acquisition {#s4f1}

Animals were anesthetized with 0.01% tetramisole and 0.1% tricaine in M9 buffer [@pgen.1003510-Kirby1], mounted on 2% agarose pads and imaged using a 60′ oil immersion objective with a Nikon Eclipse 80i microscope equipped for wide-field epifluorescence and differential interference contrast (DIC). The approximate transverse cross-section of the spermatheca was selected as the focal plane. Fluorescence excitation was provided by a Nikon Intensilight C-HGFI 130W mercury lamp. Neutral density filters were used to reduce illumination intensity to 3.1% (1/32). Fluorescence excitation light was shuttered with a SmartShutter (Sutter Instruments; Novato, CA, USA), and controlled via the camera TTL signal. A SPOT RT3 cooled charge-coupled device camera (Diagnostic Instruments; Sterling Heights, MI, USA) was used to capture images at 1 frame per second using SPOT Advanced 5 (Diagnostic Instruments). For GCaMP imaging the camera exposure time, gain, and binning were set to 75 ms, 8, and 1×1, respectively. All light was redirected to the camera, and the DIC analyzer was removed from the light path. The same microscopy setup was used for all experiments. Room temperature was maintained between 20 and 23°C.

### Image processing {#s4f2}

Images were acquired at 1600×1200 pixels and saved as 8-bit tagged image file format (TIFF) files. All image processing was done using ImageJ (National Institutes of Health; Bethesda, MD, USA; <http://rsb.info.nih.gov/ij/>). The GCaMP signal was measured by defining a region of interest around the spermatheca with a standard size of 800×400 pixels (100 µm×50 µm). The mean pixel intensity (total pixel intensity/area) for each frame was then calculated using a custom ImageJ macro. We expressed the GCaMP signal (F) as a ratio with the baseline fluorescence (F0). The baseline fluorescence was calculated as the mean fluorescence of 30 frames preceding the ovulation. Data analysis and plotting were performed with GraphPad Prism 5. Kymograms were generated using a custom ImageJ macro to determine the mean fluorescence intensity of each column of pixels and represent it as a single pixel in the kymogram. Videos were exported as Audio Video Interleave (AVI) files from ImageJ and subsequently encoded as QuickTime (Apple; Cupertino, CA, USA) H.264 movies and scaled down to 400×200 pixels.

Supporting Information {#s5}
======================

###### 

Ratiometric calcium imaging. *tdTomato*, a red fluorescent protein, and *GCaMP* were co-expressed in the spermatheca under the control of the *fln-1* promoter (*xbEx1232*). tdTomato was used to detect changes in fluorescence due to shape changes of the spermatheca. tdTomato coding sequence was inserted downstream of the *fln-1* promoter in pUN85 using BamHI and EcoRI restriction sites to create pUN264. Acquisition was performed essentially as described in the methods, but with modifications to enable dual channel acquisition. A filter wheel (Sutter Instruments; Novato, CA, USA) equipped with GFP and mCherry excitation filters was used to control the excitation light wavelength, and a dual bandpass emission filter was used for imaging. The magenta trace represents tdTomato, the green trace represents GCaMP, and the black trace represents GCaMP/tdTomato. The black trace essentially overlaps the green trace indicating that spermathecal shape changes do not significantly affect the fluorescence signal (n = 3).

(EPS)

###### 

Click here for additional data file.

###### 

Subsequent ovulations show similar calcium signaling events. Representative calcium signaling trace of a second ovulation imaged with *xbIs1101\[fln-1p::GCaMP\]*. The spermathecal transit occurs more rapidly compared to the first ovulation, and the calcium pulses are of lower intensity.

(EPS)

###### 

Click here for additional data file.

###### 

Oocyte fertilization is not required for normal calcium signaling. *spe-41(sy693)* animals have a partially penetrant fertilization defect that was used to image calcium in animals with (A) fertilized or (B) unfertilized oocytes with *xbIs1101\[fln-1p::GCaMP\]*. Fertilization events were determined with DIC by examining the oocytes for incipient cell division following exit from the spermatheca. No differences between *spe-41(sy693)* (A) fertilized and (B) unfertilized and wildtype ovulations were observed. In many instances the oocyte was fertilized while exiting the spermatheca, which resulted in rounded embryos.

(EPS)

###### 

Click here for additional data file.

###### 

*itr-1(gf)* and *lfe-2(lf)* do not perturb calcium signaling in wildtype animals. Representative calcium signaling traces in (A) *itr-1(sy290gf)* (n = 5) and (B) *lfe-2(sy326)* (n = 4) animals imaged with *xbIs1101\[fln-1p::GCaMP\]*. The calcium transients have a marginally higher intensity than wildtype animals, but are not overtly different. Calcium signaling in *lfe-2(sy326)* animals is variable, which is consistent with the observed greater variability in brood sizes.

(EPS)

###### 

Click here for additional data file.

###### 

Strains used in this study.

(XLS)

###### 

Click here for additional data file.

###### 

Primer sequences.

(XLS)

###### 

Click here for additional data file.

###### 

Calcium oscillations during wildtype spermathecal transit

A representative wildtype spermathecal transit imaged using *xbIs1101\[fln-1p::GCaMP\]*. Oocyte entry occurs from the right at 30 seconds. The sp-ut valve is constricted until it begins to dilate at six minutes, and exit is complete by 10 minutes. After an initial pulse of calcium in the sp-ut valve, calcium transients originate in the distal spermatheca (right) and propagate to the proximal spermatheca, in the direction of oocyte movement. Following embryo exit the sp-ut valve constricts in response to calcium release. The sujc core cell is visible below the embryo. The movie is shown twenty times faster than real-time with a lookup table to visualize low intensities (cool colors represent low intensity). Time is shown as minutes:seconds and begins 30 seconds before oocyte entry. The entire region shown (100 µm×50 µm) was used for the mean fluorescence intensity measurements in [Figure 4A](#pgen-1003510-g004){ref-type="fig"}.

(MP4)

###### 

Click here for additional data file.

###### 

Calcium-insensitive GFP fluorescence is not altered by oocyte passage. A representative wildtype spermathecal transit imaged using *xbIs1101\[fln-1p::GCaMP\]*. Oocyte entry occurs from the right at 30 seconds. The sp-ut valve is constricted until it begins to dilate at 6 minutes and 30 seconds, and exit is complete by 10 minutes. More compact (denser) regions of the spermatheca appear brighter; however, there is no change in the overall average fluorescence intensity due to shape changes. The sujc core cell is visible below the embryo. The movie is shown twenty times faster than real-time with a lookup table to visualize low intensities (cool colors represent low intensity). Time is shown as minutes:seconds and begins 30 seconds before oocyte entry. The entire region shown (100 µm×50 µm) was used for the mean fluorescence intensity measurements in [Figure 4C](#pgen-1003510-g004){ref-type="fig"}.

(MP4)

###### 

Click here for additional data file.

###### 

INX-12 is required for synchronous calcium waves. A representative *inx-12(RNAi)* spermathecal transit imaged using *xbIs1101\[fln-1p::GCaMP\]*. Oocyte entry occurs from the right at 30 seconds. Calcium flashes are evident in cells, but there is minimal synchronization between cells. Initially the oocyte is moving towards the sp-ut valve, but an increase in calcium signaling in the proximal spermatheca propels the oocyte towards the ovary. An increase in calcium signaling in the distal spermatheca at 17 minutes pushes the oocyte towards the sp-ut valve. Finally, a bright pulse of calcium in the proximal spermatheca and the sp-ut valve pushes the embryo into the ovary. The movie is shown twenty times faster than real-time with a lookup table to visualize low intensities (cool colors represent low intensity). Time is shown as minutes∶seconds and begins 30 seconds before oocyte entry. The entire region shown (100 µm×50 µm) was used for the mean fluorescence intensity measurements in [Figure 5](#pgen-1003510-g005){ref-type="fig"}.

(MP4)

###### 

Click here for additional data file.

###### 

FLN-1 is necessary to trigger calcium signaling. A representative *fln-1(tm545)* spermathecal transit imaged using *xbIs1101\[fln-1p::GCaMP\]*. Oocyte entry occurs from the right at 30 seconds. The sp-ut valve is not constricted despite a pulse of calcium during entry (1 minute) and it appears to dilate, but the oocyte does not exit. During the first ten minutes there is limited calcium release in the distal spermatheca and little constriction. After the first ten minutes stronger calcium pulses commence, and the oocyte moves slightly towards the sp-ut valve wedging it open. The movie is shown twenty times faster than real-time with a lookup table to visualize low intensities (cool colors represent low intensity). Time is shown as minutes∶seconds and begins 30 seconds before oocyte entry. The entire region shown (100 µm×50 µm) was used for the mean fluorescence intensity measurements in [Figure 6A](#pgen-1003510-g006){ref-type="fig"}.

(MP4)

###### 

Click here for additional data file.

###### 

PLC-1 is required for calcium release in the spermatheca. A representative *plc-1(rx1)* spermathecal transit imaged using *xbIs1101\[fln-1p::GCaMP\]*. Oocyte entry occurs from the right at 30 seconds. The sp-ut valve is constricted initially and appears to loosen at several points, but never dilates. There is limited calcium signaling in the neck of the spermatheca that quickly diminishes. The movie is shown twenty times faster than real-time with a lookup table to visualize low intensities (cool colors represent low intensity). Time is shown as minutes∶seconds and begins 30 seconds before oocyte entry. The entire region shown (100 µm×50 µm) was used for the mean fluorescence intensity measurements in [Figure 6B](#pgen-1003510-g006){ref-type="fig"}.

(MP4)

###### 

Click here for additional data file.

###### 

Loss of PLC-1 in the *fln-1(tm545)* background abrogates delayed calcium release. A representative *fln-1(tm545); plc-1(rx1)* spermathecal transit imaged using *xbIs1101\[fln-1p::GCaMP\]*. Oocyte entry occurs from the right at 30 seconds. The sp-ut valve is not tightly constricted, and oocyte entry appears to slightly open the valve. The calcium signaling is largely eliminated, but the few spontaneous bursts of calcium may move the embryo forward slightly. The movie is shown twenty times faster than real-time with a lookup table to visualize low intensities (cool colors represent low intensity). Time is shown as minutes∶seconds and begins 30 seconds before oocyte entry. The entire region shown (100 µm×50 µm) was used for the mean fluorescence intensity measurements in [Figure 6C](#pgen-1003510-g006){ref-type="fig"}.

(MP4)

###### 

Click here for additional data file.

###### 

*itr-1(sy290gf)* increases calcium release in *fln-1(tm545)* animals. A representative *fln-1(tm545) itr-1(sy290gf)* spermathecal transit imaged using *xbIs1101\[fln-1p::GCaMP\]*. Oocyte entry occurs from the right at 30 seconds. The sp-ut valve is not constricted and oocyte entry partially dilates the valve. Increased calcium signaling compared to *fln-1(tm545)* single mutant animals pushes the oocyte partially out of the spermatheca. The movie is shown twenty times faster than real-time with a lookup table to visualize low intensities (cool colors represent low intensity). Time is shown as minutes∶seconds and begins 30 seconds before oocyte entry. The entire region shown (100 µm×50 µm) was used for the mean fluorescence intensity measurements in [Figure 7A](#pgen-1003510-g007){ref-type="fig"}.

(MP4)

###### 

Click here for additional data file.

###### 

*lfe-2(sy326)* increases calcium release in *fln-1(tm545)* animals. A representative *fln-1(tm545)*; *lfe-2(sy326)* spermathecal transit imaged using *xbIs1101\[fln-1p::GCaMP\]*. Oocyte entry occurs from the right at 30 seconds. The sp-ut valve is not constricted and oocyte entry partially dilates the valve. Increased calcium signaling compared to *fln-1(tm545)* single mutant animals pushes the oocyte partially out of the spermatheca. The movie is shown twenty times faster than real-time with a lookup table to visualize low intensities (cool colors represent low intensity). Time is shown as minutes∶seconds and begins 30 seconds before oocyte entry. The entire region shown (100 µm×50 µm) was used for the mean fluorescence intensity measurements in [Figure 7B](#pgen-1003510-g007){ref-type="fig"}.
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Click here for additional data file.

###### 

*mel-11(RNAi)* causes spermathecal rupture. A representative *mel-11(RNAi)* spermathecal transit imaged with DIC microscopy. Oocyte entry begins at 1 minute, but the spermatheca appears hyper-constricted and initially resists the oocyte entry. The spermatheca begins to rupture at 15 minutes and 30 seconds on the dorsal surface (ventral is down), and the embryo escapes shortly after. Sperm can also be seen leaving the spermatheca via the rupture. The movie is shown twenty times faster than real-time. Time is shown as minutes∶seconds and begins 30 seconds before oocyte entry.

(MP4)

###### 

Click here for additional data file.
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